Invernizzi_EU Haematology 03/03/2010 16:47 Page 38
Myelodysplastic Syndromes
1. Invernizzi R., The role of apoptosis in myelodysplastic leukemia?, Cancer Res, 2007;67:8762–71. 39. azzola M, Invernizzi R., Sideroblastic anemias, in: Young
syndrome, Haematologica, 2002;87:337–9. 19. Erkeland SJ, Palande KK, Valkhof M, et al., The gene NS, Gerson SL, High KA (eds.), Clinical Hematology,
2. Cazzola M, Malcovati L, Myelodysplastic syndromes- encoding thioredoxin-interacting protein (TXNIP) is a Philadelphia, Mosby Elsevier, 2005:721–32.
coping with ineffective hematopoiesis, N Engl J Med, frequent virus integration site in virus-induced mouse 40. Cazzola M, Barosi G, Gobbi PG, et al., Natural history of
2005;352:536–3. leukemia and is overexpressed in a subset of AML idiopathic refractory sideroblastic anemia, Blood,
3. Fontenay M, Gyan E, Apoptotic pathways to death in patients, Leuk Res, 2009;33:1367–71. 1988;71:305–12.
myelodysplastic syndromes, Haematologica, 20. Ito K, Hirao A, Arai F, et al., Regulation of oxidative stress 41. Malcovati L, Porta MG, Pascutto C, et al., Prognostic
2008;93:1288–92. by ATM is required for self-renewal of haematopoietic factors and life expectancy in myelodysplastic
4. Invernizzi R, Travaglino E, Increased apoptosis as a stem cells, Nature, 2004;431:997–1002. syndromes classified according to WHO criteria: a basis
mechanism of ineffective erythropoiesis in 21. Ito K, Hirao A, Arai F, et al., Reactive oxygen species act for clinical decision making, J Clin Oncol,
myelodysplastic syndromes, Clinical Leukemia, through p38 MAPK to limit the lifespan of hematopoietic 2005;23:7594–7603.
2008;2:113–20. stem cells, Nat Med, 2006;12:446–51. 42. Malcovati L, Germing U, Kuendgen A, et al., Time-
5. Parker JE, Mufti GJ, Rasool F, et al., The role of apoptosis, 22. Navas TA, Mohindru M, Estes M, et al., Inhibition of dependent prognostic scoring system for predicting
proliferation, and Bcl-2-related proteins in the overactivated p38 MAPK can restore hematopoiesis in survival and leukemic evolution in myelodysplastic
myelodysplastic syndromes and acute myeloid myelodysplastic syndrome progenitors, Blood, syndromes, J Clin Oncol, 2007;25:3503–10.
leukaemia secondary to MDS, Blood, 2000;96:3932–8. 2006;108:4170–77. 43. Armand P, Kim HT, Cutler CS, et al., Prognostic impact of
6. Pecci A, Travaglino E, Klersy C, et al., Apoptosis in relation 23. Ghaffari S, Oxidative stress in the regulation of normal elevated pretransplantation serum ferritin in patients
to CD34 antigen expression in normal and and neoplastic hematopoiesis, Antioxid Redox Signal, undergoing myeloablative stem cell transplantation,
myelodysplastic bone marrow, Acta Haematol, 2008;10:1923–40. Blood, 2007;109:4586–8.
2003;109:29–34. 24. Nimer SD, MDS: a stem cell disorder-but what exactly is 44. Farquhar MJ, Bowen DT, Oxidative stress and the
7. Invernizzi R, Travaglino E, Lunghi M, et al., Survivin wrong with the primitive hematopoietic cells in this myelodysplastic syndromes, Int J Hematol, 2003;77:342–50.
expression in acute leukemias and myelodysplastic disease? Hematology Am Soc Hematol Educ Program, 45. Choi SO, Cho YS, Kim HL, et al., ROS mediate the hypoxic
syndromes, Leuk Lymphoma, 2004;45:2229–37. 2008:43–51. repression of the hepcidin gene by inhibiting C/EBP-
8. Peddie CM, Wolf CR, McLellan LI, et al., Oxidative DNA 25. Arosio P, Levi S, Ferritin, homeostasis, and oxidative alpha and STAT-3, Biochem Biophys Res Commun,
damage in CD34+ myelodysplastic cells is associated damage, Free Radic Biol Med, 2002;33:457–63. 2007;356:312–17.
with intracellular redox changes and elevated plasma 26. Esposito BP, Breuer W, Sirankapracha P, et al., Labile 46. Ghoti H, Fibach E, Merkel D, et al., Decrease in intra- and
tumor necrosis factor-alpha concentration, Br J Haematol, plasma iron in iron overload: redox activity and extra-cellular free iron species and oxidative stress
1997;99:625–31. susceptibility to chelation, Blood, 2003;102:2670–77. parameters and increase in serum and urinary hepcidin
9. Pham CG, Bubici C, Zazzeroni F, et al., Ferritin heavy 27. Hershko C, Link G, Cabantchik I, Pathophysiology of iron during treatment with deferasirox in iron-loaded patients
chain upregulation by NF-kappaB inhibits TNFalpha- overload, Ann N Y Acad Sci, 1998;850:191–201. with MDS, Haematologica, 2009;94(suppl 2):322.
induced apoptosis by suppressing reactive oxygen 28. Arosio P, Ingrassia R, Cavadini P, Ferritins: a family of 47. Camaschella C, Recent advances in the understanding of
species, Cell, 2004;119:529–42. molecole for iron storage, antioxidation and more, Biochim inherited sideroblastic anaemia, Br J Haematol, 2008;143:
10. Cortelezzi A, Cattaneo C, Cristiani S, et al., Non- Biophys Acta, 2009;1790:589–99. 27–38.
transferin-bound iron in myelodysplastic sindrome: a 29. Napier I, Ponka P, Richardson DR, Iron trafficking in the 48. Cazzola M, Invernizzi R, Bergamaschi G, et al.,
marker of ineffective erythropoiesis?, Hematol J, mitochondrion: novel pathways revealed by disease, Mitochondrial ferritin expression in erythroid cells from
2000;1:153–8. Blood, 2005;105:1867–74. patients with sideroblastic anemia, Blood, 2003;101:
11. Novotna B, Bagryantseva Y, Siskova M, et al., Oxidative 30. Levi S, Rovida E, The role of iron in mitochondrial 1996–2000.
DNA damage in bone marrow cells of patients with low- function, Biochim Biophys Acta, 2009;1790:629–36. 49. Tehranchi R, Invernizzi R, Grandien A, et al., Aberrant
risk myelodysplastic syndrome, Leuk Res, 2009;33:340–43. 31. Levi S, Corsi B, Bosisio M, et al., A human mitochondrial mitochondrial iron distribution and maturation arrest
12. Honda M, Yamada Y, Tomonaga M, et al., Correlation of ferritin encoded by an intronless gene, J Biol Chem, characterize early erythroid precursors in low-risk
urinary 8-hydroxy-2’-deoxyguanosine (8-OHdG), a 2001;276:24437–40. myelodysplastic syndromes, Blood, 2005;106:247–53.
biomarker of oxidative DNA damage, and clinical 32. Drysdale J, Arosio P, Invernizzi R, et al., Mitochondrial 50. Lu Z, Nie G, Li Y, et al., Overexpression of mitochondrial
features of hematological disorders: a pilot study, Leuk ferritin: a new player in iron metabolism, Blood Cells Mol ferritin sensitizes cells to oxidative stress via an iron-
Res, 2000;24:461–8. Dis, 2002;29:376–83. mediated mechanism, Antioxid Redox Signal, 2009;11(8):
13. Jankowska AM, Gondek LP, Szpurka H, et al., Base 33. Campanella A, Rovelli E, Santambrogio P, et al., 1791–1803.
excision repair dysfunction in a subgroup of patients Mitochondrial ferritin limits oxidative damage regulating 51. Pellagatti A, Cazzola M, Giagounidis AA, et al., Gene
with myelodysplastic syndrome, Leukemia, 2008;22:551–8. mitochondrial iron availability: hypothesis for a protective expression profiles of CD34+ cells in myelodysplastic
14. Ghoti H, Amer J, Winder A, et al., Oxidative stress in red role in Friedreich ataxia, Hum Mol Genet, 2009;18:1–11. syndromes: involvement of interferon-stimulated genes
blood cells, platelets and polymorphonuclear leukocytes 34. Nie G, Sheftel AD, Kim SF, et al., Overexpression of and correlation to FAB subtype and karyotype, Blood,
from patients with myelodysplastic syndrome, Eur J mitochondrial ferritin causes cytosolic iron depletion and 2006;108:337–45.
Haematol, 2007;79:463–67. changes cellular iron homeostasis, Blood, 2005;105: 52. Boultwood J, Pellagatti A, Nikpour M, et al., The role of
15. Gonçalves AC, Cortesao E, Alves V, et al., CD34 cells are 2161–7. the iron transporter ABCB7 in refractory anemia with ring
under oxidative stress - Possible implication in MDS 35. Nie G, Chen G, Sheftel AD, et al., In vivo tumor growth is sideroblasts, PLoS ONE, 2008;3: e1970.
pathogenesis, Haematologica, 2009;94(Suppl. 2):323. inhibited by cytosolic iron deprivation caused by the 53. Invernizzi R, Travaglino E, Della Porta MG, et al.,
16. Fracchiolla NS, Bamonti Catena F, Novembrino C, et al., expression of mitochondrial ferritin, Blood, 2006;108: Characterization of a cellular model for the study of
Possible association between reactive oxygen 2428–34. mitochondrial ferritin physiopathological role in
metabolites and karyotypic abnormalities in 36. Cazzola M, Della Porta MG, Malcovati L, Clinical sideroblastic erythropoiesis, Haematologica, 2008;93
myelodysplastic syndromes, Haematologica, 2003;88:594–7. relevance of anemia and transfusion iron overload in (Suppl. 2):S17.
17. Bowen D, Wang L, Frew M, et al., Antioxidant enzyme myelodysplastic syndromes, Hematology Am Soc Hematol 54. Craven SE, French D, Ye W, et al., Loss of HSPA9B
expression in myelodysplastic and acute myeloid Educ Program, 2008:166–75. zebrafish recapitulates the ineffective hematopoiesis of
leukemia bone marrow: further evidence of a 37. Gattermann N, Clinical consequences of iron overload in the myelodysplastic syndrome, Blood, 2005;105:3528–34.
pathogenetic role for oxidative stress?, Haematologica, myelodysplastic syndromes and treatment with 55. Martin FM, Bydlon G, Friedman JS, SOD2-deficiency
2003;88:1070–72. chelators, Hematol Oncol Clin North Am, 2005;19(Suppl. sideroblastic anemia and red blood cell oxidative stress,
18. Rassool FV, Gaymes TJ, Omidvar N, et al., Reactive 1):13–17. Antioxid Redox Signal, 2006;8:1217–25.
oxygen species, DNA damage and error prone repair: A 38. Nemeth E, Ganz T, Hepcidin and iron-loading anemias,
model for genomic instability with progression in myeloid Haematologica, 2006;91:727–32.
38 EUROPEAN HAEMATOLOGY
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100